Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001220756 | SCV001392765 | benign | Tuberous sclerosis 2 | 2022-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002339583 | SCV002643755 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-10-06 | criteria provided, single submitter | clinical testing | The p.S173F variant (also known as c.518C>T), located in coding exon 5 of the TSC2 gene, results from a C to T substitution at nucleotide position 518. The serine at codon 173 is replaced by phenylalanine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV004010736 | SCV004833810 | uncertain significance | Tuberous sclerosis syndrome | 2023-05-08 | criteria provided, single submitter | clinical testing |